Bot Chart, page-7963

Having being through the acne debacle (and similarly valued as we are now by the way) at that point, I could not be more bullish.

Acne was in phase 2 and valued at the same market cap we sit at now.

We now have SB, BTX1801, BTX 1503 and BTX 1702. Which are even more advanced then they were 2 years ago.

SB sells well in Japan and already has approval.

We have strong phase 3 US based data for SB with no issues identified whatsoever in the mid cycle review.

We are already earning royalties in overseas markets.

We have a world class team that between them have 25 FDA approvals between them.

I hold 4.3 million shares in this company. Im already up a significant amount of money. Once FDA approval comes through we are on for one of the biggest journeys and transformations ever for this company. The revenue opportunities are insane with SB and our diversified pipeline.

Where else can you find a story like this at such a ridiculously cheap valuation?

This company will be worth billions of dollars shortly and Vinnie will be smiling when big pharma comes knocking.